Activity of venetoclax in patients with relapsed or refractory chronic lymphocytic leukaemia: analysis of the VENICE-1 multicentre, open-label, single-arm, phase 3b trial
2024 · The Lancet Oncology · 33 citations
https://doi.org/10.1016/s1470-2045(24)00070-6